Healthline: What we know about Eli Lilly’s experimental weight-loss drug
UC expert says weight loss often doesn’t last long term
According to drugmaker Eli Lilly, participants in a clinical trial lost over 50 pounds on average when they were treated with the highest dose of a new hunger suppressant.
The drug, called tirzepatide, is making headlines, but has not yet been approved or authorized by the Food and Drug Administration. Additionally, the initial research has been made public by the drug maker Eli Lilly and has not yet been published in a peer-reviewed medical journal.
In a story on the drug published by Healthline, one of the experts quoted is Shailendra Patel, MD, PhD, Division of Endocrinology, Diabetes and Metabolism in the Department of Internal Medicine at the UC College of Medicine.
Shailendra Patel, MD, PhD, Division of Endocrinology, Diabetes and Metabolism at the UC College of Medicine/Photo/Colleen Kelley/UC Creative + Brand
Patel told Healthline that approaches to weight loss have typically involved dieting but that diets often result only in short term weight loss because they are extremely difficult to stick with for an indefinite period of time.
“The reason that all these diets fail is that human beings cannot stick with any one of these diet plans forever,” he said.
Patel points out that due to the complexity of obesity relying on a single solution, whether a diet or a pill, is likely not going to work long term.
“We have yet another weight loss drug to help patients," said Patel. “But drugs by themselves, just like crash diets by themselves, you can see weight loss – but you won’t be successful.”
He said if people with obesity want to lose weight it may require multiple interventions some of which may include medical interventions.
Patel pointed out that even bariatric surgery, which involves shrinking or bypassing the stomach through surgery, requires patients to change their long-term approach to diet and exercise for the best results.
Lead photo/Darron Cummings/AP
Impact Lives Here
The University of Cincinnati is leading public urban universities into a new era of innovation and impact. Our faculty, staff and students are saving lives, changing outcomes and bending the future in our city's direction. Next Lives Here.
Related Stories
Driven by curiosity, guided by care
May 14, 2026
Max Wilson, a University of Cincinnati College of Allied Health Sciences health sciences major on the pre-physician assistant track, found his path expanding beyond the classroom and into hands-on research focused on human performance and patient care.
New cohort of nursing students get ready to join co-ops
May 14, 2026
A new chapter is beginning for more than 100 University of Cincinnati College of Nursing rising seniors as they embark on one of the most distinctive experiences in undergraduate nursing education: the UC Nursing Co-op Program. The incoming cohort will fan out across Cincinnati's premier healthcare institutions, stepping into some of the most dynamic and specialized clinical environments in the region. Placement sites include UC Medical Center (UCMC), West Chester Hospital, Cincinnati Children's Hospital Medical Center (CCHMC) Burnet, College Hill, and Liberty campus.
Will a gas tax help lower prices at the pump?
May 14, 2026
WCPO recently reported on Kentucky and Indiana’s steps to combat surging gas prices, cutting and suspending state gas taxes, respectively. UC economist Michael Jones explained the impact on Cincinnati.